Jessica A. Gonzalez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Anticancer effects of an XPO1 inhibitor (selinexor) with sotorasib following omeprazole preconditioning in KRAS G12C-mutant non-small cell lung cancer cells in vitro and in a mouse tumor xenograft.

Anticancer effects of an XPO1 inhibitor (selinexor) with sotorasib following omeprazole preconditioning in KRAS G12C-mutant non-small cell lung cancer cells in vitro and in a mouse tumor xenograft.

Journal: Neoplasia (New York, N.Y.)

Published: July 10, 2026

Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived Sézary syndrome cells.

Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived Sézary syndrome cells.

Journal: The Journal of investigative dermatology

Published: August 05, 2025

CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness.

CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness.

Journal: Leukemia

Published: August 05, 2025

Cetuximab co-treatment with KRAS G12C inhibitors fulzerasib and sotorasib in human KRAS G12C non-small cell lung cancer cells.

Cetuximab co-treatment with KRAS G12C inhibitors fulzerasib and sotorasib in human KRAS G12C non-small cell lung cancer cells.

Journal: Cell death discovery

Published: July 24, 2025

An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells.

An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells.

Journal: Blood

Published: November 19, 2024

A Notch trans-activation to cis-inhibition switch underlies hematopoietic stem cell aging.

A Notch trans-activation to cis-inhibition switch underlies hematopoietic stem cell aging.

Journal: Blood

Published: August 09, 2024

KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination.

KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination.

Journal: Cell communication and signaling : CCS

Published: December 04, 2023

KRAS G12C-mutant driven non-small cell lung cancer (NSCLC).

KRAS G12C-mutant driven non-small cell lung cancer (NSCLC).

Journal: Critical reviews in oncology/hematology

Published: November 30, 2023

A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin.

A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin.

Journal: Frontiers in cell and developmental biology

Published: September 12, 2023

Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling.

Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 13, 2023

IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development.

IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development.

Journal: Nature communications

Published: December 14, 2022

SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex.

SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex.

Journal: Nucleic acids research

Published: September 22, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026